Trupanion, Inc. (NASDAQ:TRUP) Stock Holdings Lessened by Kopion Asset Management LLC

Kopion Asset Management LLC reduced its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 39.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 305,614 shares of the financial services provider's stock after selling 195,200 shares during the period. Trupanion comprises approximately 9.2% of Kopion Asset Management LLC's portfolio, making the stock its 2nd biggest holding. Kopion Asset Management LLC owned about 0.72% of Trupanion worth $12,830,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. GAMMA Investing LLC grew its holdings in shares of Trupanion by 70.4% in the third quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider's stock worth $61,000 after purchasing an additional 596 shares during the last quarter. Headlands Technologies LLC bought a new position in shares of Trupanion in the second quarter worth approximately $162,000. Oppenheimer Asset Management Inc. bought a new position in shares of Trupanion in the second quarter worth approximately $235,000. Handelsbanken Fonder AB bought a new position in shares of Trupanion in the third quarter worth approximately $248,000. Finally, Bayesian Capital Management LP bought a new position in shares of Trupanion in the first quarter worth approximately $253,000.

Trupanion Stock Up 5.1 %

Trupanion stock traded up $2.61 on Wednesday, hitting $53.50. 758,263 shares of the stock traded hands, compared to its average volume of 682,127. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. The firm has a market cap of $2.25 billion, a P/E ratio of -83.16 and a beta of 1.73. The business's fifty day simple moving average is $43.80 and its 200 day simple moving average is $33.76. Trupanion, Inc. has a 1 year low of $19.14 and a 1 year high of $54.08.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.04. The firm had revenue of $314.80 million during the quarter, compared to analyst estimates of $309.33 million. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. Trupanion's quarterly revenue was up 16.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.33) EPS. As a group, sell-side analysts forecast that Trupanion, Inc. will post -0.34 earnings per share for the current year.

Insider Transactions at Trupanion

In related news, CEO Margaret Tooth sold 7,500 shares of Trupanion stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the sale, the chief executive officer now directly owns 99,984 shares in the company, valued at approximately $4,647,256.32. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CFO Fawwad Qureshi sold 624 shares of the business's stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Margaret Tooth sold 7,500 shares of the business's stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the transaction, the chief executive officer now directly owns 99,984 shares in the company, valued at approximately $4,647,256.32. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 8,764 shares of company stock valued at $405,238 in the last quarter. 5.50% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of brokerages recently commented on TRUP. Bank of America raised their price target on Trupanion from $47.00 to $56.00 and gave the stock a "buy" rating in a research note on Friday, September 20th. Piper Sandler raised their price target on Trupanion from $38.00 to $45.00 and gave the stock a "neutral" rating in a research note on Wednesday, October 2nd. Evercore ISI raised Trupanion to a "strong-buy" rating in a research note on Friday, August 9th. William Blair began coverage on Trupanion in a research note on Friday, July 19th. They issued an "outperform" rating for the company. Finally, Northland Securities raised their price target on Trupanion from $35.00 to $45.00 and gave the stock a "market perform" rating in a research note on Thursday, September 19th. Four investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $41.83.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.